Published peptide research references
Cyclosporine
Governed registry record
4 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.
Approved source records
A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).
DOI: 10.1111/j.1600-6143.2009.03005.x
Source identity and connection checked by Codex (AI).
Cyclosporine A improves the binding of mouse embryos to fibronectin.
Source identity and connection checked by Codex (AI).
Daprodustat prevents cyclosporine-A-mediated anemia and peritubular capillary loss.
DOI: 10.1016/j.kint.2022.04.025
Source identity and connection checked by Codex (AI).
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
Source identity and connection checked by Codex (AI).
Legacy research context
Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.
Researchers represented
- Fervenza FC
- Appel GB
- Barbour SJ
- Rovin BH
- Lafayette RA
- Aslam N
- Jefferson JA
- Gipson PE
- Rizk DV
- Sedor JR
- Simon JF
- McCarthy ET
- Brenchley P
- Sethi S
- Avila-Casado C
- Beanlands H
- Lieske JC
- Philibert D
- Li T
- Thomas LF
- Green DF
- Juncos LA
- Beara-Lasic L
- Blumenthal SS
- Sussman AN
- Erickson SB
- Hladunewich M
- Canetta PA
- Hebert LA
- Leung N
- Radhakrishnan J
- Reich HN
- Parikh SV
- Gipson DS
- Lee DK
- da Costa BR
- Jüni P
- Cattran DC
- MENTOR Investigators
- Vincenti F
- Charpentier B
- Vanrenterghem Y
- Rostaing L
- Bresnahan B
- Darji P
- Massari P
- Mondragon-Ramirez GA
- Agarwal M
- Di Russo G
- Lin CS
- Garg P
- Larsen CP
- Shengnan T
- Mei Z
- Jiaxing W
- Dan L
- YanLin M
- Huang Y
- Labes R
- Brinkmann L
- Kulow VA
- Roegner K
- Mathia S
- Balcerek B
- Persson PB
- Rosenberger C
- Fähling M